Open Accessibility Menu

Celebrating Four Decades of Quality Care ~ 1982 - 2022

CurePSP and Griswold Home Care Franchise Partner to Provide Care

CurePSP, the leading nonprofit advocacy organization focused on prime of life neurodegenerative diseases, has announced an exclusive, nationwide partnership with Griswold Home Care to provide in-home services for people suffering from progressive supranuclear palsy (PSP). The arrangement means delivery of care to PSP patients who need assistance with everyday tasks such as walking, navigating, and eating, and whose symptoms can include vision problems, balance and gait issues, difficulty chewing and swallowing, and frequent falls.

PSP is a debilitating, progressive brain disorder that has no treatment or cure and often places families under devastating financial and emotional burdens.

“Being able to care for their loved one at home as long as possible is important for many families, but the cost of home care is prohibitive for most,” said Trish Caruana, Vice President – Patient and Carepartner Advocacy at CurePSP. “At the same time, people with PSP often need intensive assistance with routine activities. We’re very comfortable with Griswold’s experience delivering the type of care they need.”

The partnership was made possible through a gift to CurePSP by Lawrence Levien and family in loving memory of Cherie Levien, who passed away from PSP in 2016. The Cherie Levien Quality of Life Legacy Fund, administered by CurePSP, provides grants to families struggling with the burden of caregiving to enlist the services of Griswold Home Care to provide quality in-home care for their loved one. More information on the Cherie Levien Quality of Life Fund can be found at

“We are very honored to not only be a partner with CurePSP in raising much-needed awareness of these neurodegenerative diseases, but to also help provide the personalized care that can make a difference in the lives of individuals and families impacted by these conditions,” said Matt Murphy, CEO of Griswold Home Care.